Market Overview

OvaScience, Intrexon Collaborate on OvaScience's OvaTure Technology for Infertility Treatments

Related OVAS
OvaScience Announces Proposed Public Offering of Common Stock
OvaScience Issued Two U.S. Patents Covering AUGMENT℠ Fertility Treatment

OvaScience, (NASDAQ: OVAS) and Intrexon Corporation (NYSE: XON) today announced an agreement to access Intrexon's portfolio of
technologies to accelerate the development of OvaScience's OvaTure℠
technology platform. Separately, the companies established a Joint
Venture, called OvaXon, to combine their unique technology platforms to
create new applications for improving human and animal health.

See full press release

Posted-In: News Guidance Offerings Contracts Global

 

Most Popular

Related Articles (XON + OVAS)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free